1. Sela S, Shurtz-Swirski R, Hamzi M, Shapiro G, Shasha SM and Kristal B. Oxidative stress during hemodialysis: effect of heparin. Kidney Int 59:S159-163, 2001.

2. Mashiach E, Sela S, Weinstein T, Cohen HI, Shasha SM and Kristal B. Mesna: a novel renoprotective antioxidant in ischemic acute renal failure. Nephrol Dial Transplant 16:542-551, 2001.


3. Shurtz-Swirski R, Sela S, Herskovits AT, Shasha SM, Shapiro G, Nasser L and Kristal B. The involvement of peripheral polymorphonuclear leukocytes  in oxidative stress and inflammation in type 2 diabetic patients. Diabetes Care 24:104-110, 2001.

4. Sela S, Shurtz-Swirski R, Sharon R, Manaster J, Chezar J, Shkolnik G, Shapiro G, Shasha SM, Merchav S and Kristal B. The polymorphonuclear leukocyte – a new target for erythropoietin . Nephron 88:205-210, 2001.

5. Sela S, Shurtz-Swirski R, Farah R, Levy R, Shapiro G, Chezar J, Shasha SM, and Kristal B. A link between polymorphonuclear leukocyte intracellular calcium, plasma Insulin and essential hypertension. Am J Hypertens 15:291-295, 2002.

6.  Kristal B, Shurtz-Swirski R, Hassan K, Shasha SM, Shapiro G and Sela S. Interaction between erythropoietin  and peripheral polymorphonuclear leukocytes in continuous ambulatory dialysis patients. Nephron 91(4);759-761, 2002.

7. Sela S, Shurtz-Swirski R, Awad J, Shapiro G, Nasser L, Shasha SM,  and Kristal B. Oxidative stress and inflammation in cigarette smoking: The Involvement of Peripheral Polymorphonuclear Leukocytes in the Oxidative Stress and Inflammation in Cigarette Smokers. Isr Med Assoc J, 4(11):1015-1019,2002.

8.  Fait V, Sela S, Ophir E, Khoury S, Nissimov J, Tkach M, Hirsh Y, Khotaba S, Tarasova   L, Oettinger M. Hyperemesis gravidarum is associated with oxidative stress. Am J Perinatol 19(2):93-8, 2002.

9. Michelis R, Gery R, Sela S, Shurtz-Swirski R.Grinberg N, Snitkovski T,Shasha SM, Kristal B. Carbonyl stress induced by intravenous iron during haemodialysis.
Nephrol Dial Transplant 18:924-930, 2003.

10. Shusterman T, Sela S, Cohen HI, Kristal B, Sbeit W and Reshef R. Effect of the antioxidant Mesna (2-mercaptoethane sulfonate) on experimental colitis. Dig Dis Sci 48:1177-1185, 2003.
11. Sela s, Mazor R, Amsalam M, Yagil C, Yagil Y, Kristal B. Primed polymorphonuclear leukocytes, oxidative stress, and inflammation antecede hypertension in the Sabra rat. Hypertension. 44(5): 764-9, 2004.

12.  Fait V, Sela S, Ophir E, Kreutzer H, Shnaider O, Perri A, Khatib N, Dourleshter G, Tendler R, Bornstein J. Peripheral polymorphonuclear leukocyte priming contributes to oxidative stress in early pregnancy. J Soc Gynecol Investig 12(1):46-49, 2005.

13. Sela S, Shurtz-Swirski R, Cohen-Mazor M, Mazor R, Chezar J, Shapiro G, Hassan K, Shkolnik G, Geron R, Kristal B. Primed peripheral polymorphonuclear leukocyte: A culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol 16: 2431-2438, 2005.

14. Michelis R, Sela S., Kristal B. Intravenous iron-gluconate during hemodialysis modifies plasma β2-microglobulin properties and levels. Nephrol Dial Transplant, Sep;20(9):1963-9, 2005.

15. Jacobi J, Kristal B, Chezar J, Shasha SM, Sela S. Exogenous superoxide mediates pro-oxidative, pro-inflammatory and procoagulatory changes in primary endothelial cell cultures. Free Radic Biol Med, 39:1238-1248, 2005.

16. Jacobi J, Sela S, Cohen HI, Chezar J, Kristal B. Priming of polymorphonuclear leukocytes –a culprit in the initiation of endothelial cell injury. Am J Physiol Heart Circ Physiol. May;290(5):H2051-8, 2006.

17. Geron R., Shurtz-Swirski R., Sela S., Gurevitch Y., Tanasjtchouk T., Shkolnik G., Tanhilevski O., Kristal B. Polymorphonuclear leukocyte priming in long intermittent nocturnal hemodialysis patients – is melatonin a player? Nephrology Dialysis Transplantation  Nov;21(11):3196-201, 2006.

18. Mazor R., Shurtz –Swirski R., Sela S., Shapiro G., Kristal B.  Polymorphonuclear leukocyte priming and counts are in correlation with blood pressure parameters. Harefuah, 145(12):900-3, 2006.

19. Revital Shurtz-Swirski, Raymond Farah, Shifra Sela, Galina Shapiro, Regina Klempef, Tamara Snitkovski,  Batya Kristal. The effect of calcium channel blocker Lercanidipine on low-grade inflammation parameters in essential hypertension patients.  Harefuah, 145(12):895-9, 2006.

20.  Farah R, Freidzon L, Sela S, Michelis R, Gross B, Sulla M. Expression of inflammatory mediators in meningitis. Harefuah. 146(6):410-3, 2007.

21. Mazor R., Kristal B., Cohen- Mazor M., Yagil C., Yagil Y. and Sela S. The Polymorphonuclear Leukocyte Contributes to the Development of Hypertension in the Sabra Rat. J Hypertens, Nov;25(11):2249-2256, 2007.

22. Bornstein J, Cohen Y, Zarfati D, Sela S, Ophir E. Involvement of heparanase in the pathogenesis of localized vulvodynia. Int J Gynecol Pathol. Jan;27(1):136-41, 2008.

23. Mazor R., Shurtz-Swirski R., Farah R., Kristal B., Shapiro G.,  Dorlechter F., Cohen-Mazor M., Meilin E., Snitkovski T. and Sela S. Primed PMNLs constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients, Atherosclerosis, 197(2):937-43, 2008.

24.  Michelis R, Sela S, Ben-Zvi I, Nagler RM. Salivary beta2-Microglobulin Analysis in Chronic Kidney Disease and Hemodialyzed  Patients. Blood Purif. Jan 11;25(5-6):505-509, 2008.

25. Cohen-Mazor M, Sela S, Mazor R, Ilan N, Vlodavsky I, Rops AL, van der Vlag J,
 Cohen HI, Kristal B. Are primed polymorphonuclear leukocytes contributors to the high heparanase levels in hemodialysis patients? Am J Physiol Heart Circ Physiol. Feb;294(2):H651-8, 2008.

26. Meilin E, Sela S, Kristal B. Heparin cryo precipitation reduces levels of non traditional risk factors for atherosclerosis in-vitro. Blood Purif 2008;26:238-248.

27. Kristal B, Shurtz-Swirski R, Tanhilevski O, Shapiro G, Shkolnik G, Chezar J,
 Snitkovsky T, Cohen-Mazor M, Sela S. Epoetin-alpha: preserving kidney function via attenuation of polymorphonuclear leukocyte priming. Isr Med Assoc J. Apr;10(4):266-72, 2008.

28. Michelis R, Sela S, Sbeit W, Cohen H.I and Reshef R. Decreased TFF2 expression in the gastric antrum in patients infected with CagA-positive Helicobacter pylori. Isr Med Assoc J. Jan;11(1):11-5, 2009.

29. Mazor R, Itzhaki O, Sela S, Yagil Y, Cohen-Mazor M, Yagil C, Kristal B. Tumor Necrosis Factor-{alpha}. A Possible Priming Agent for the Polymorphonuclear
 Leukocyte-Reduced Nicotinamide-Adenine Dinucleotide Phosphate Oxidase in
 Hypertension. Hypertension. Feb;55 (2):353-62, 2010.

30. Michelis R, Kristal B, Snitkovsky T, Sela S. Oxidative modifications impair albumin quantification. Biochem Biophys Res Commun. 2010, 401:137-142.